![Karen M. Kumor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karen M. Kumor
Hoofd Techniek/Wetenschap/O&O bij Sapphire Therapeutics, Inc.
Profiel
Karen M.
Kumor is currently working as Vice President-Clinical Research at Sapphire Therapeutics, Inc. She has a graduate and doctorate degree from The Johns Hopkins University.
Actieve functies van Karen M. Kumor
Bedrijven | Functie | Begin |
---|---|---|
Sapphire Therapeutics, Inc.
![]() Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Hoofd Techniek/Wetenschap/O&O | 12-10-2009 |
Opleiding van Karen M. Kumor
The Johns Hopkins University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Sapphire Therapeutics, Inc.
![]() Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Health Technology |